Lebrikizumab

  • Part D specialty tier in 83% of formularies (2026Q3)
  • Biologic
  • EBGLYSS

Therapy management checklist

Screening, baseline and ongoing monitoring with the label's stated frequency, hold and discontinue criteria, and counseling points, each quoted from the FDA label.

Loading the therapy management checklist…

Storage and cold chain

Lebrikizumab: storage and handling

Refrigerate
Yes, as the label states
Label statement
Store refrigerated at 2°C to 8°C (36°F to 46°F).
Freezing
Do not freeze
Label statement
Do not freeze.
Room temperature
up to 7 days at or below 30°C (86°F)
Label statement
If necessary, EBGLYSS can be stored at room temperature up to 30°C (86°F) for up to 7 days in the original carton.
Room temperature
up to 7 days
Label statement
Dispose of EBGLYSS that has been left at room temperature for longer than 7 days.
Room temperature
up to 7 days at or below 30°C (86°F)
Label statement
EBGLYSS can be stored at room temperature up to 86°F (30°C) for up to 7 days in the original carton.
Room temperature
up to 7 days
Label statement
Throw away (dispose of) EBGLYSS that has been left at room temperature for longer than 7 days.
Back into the refrigerator
Not addressed
Light
Protect from light
Label statement
Store in the original carton to protect from light until use.
Shaking
Do not shake
Label statement
Do not shake.

Temperature excursion helper

Answers only from this label's storage statements. It does not judge whether a product is still usable beyond what the label states.

Within the label's stated room-temperature allowance (up to 7 days at up to 30°C (86°F)). Follow the label's instructions for what to do next.

Entered: 1 day at up to 77°F (25°C).

If necessary, EBGLYSS can be stored at room temperature up to 30°C (86°F) for up to 7 days in the original carton.
Dispose of EBGLYSS that has been left at room temperature for longer than 7 days.
Discard the EBGLYSS single-dose prefilled pen or prefilled syringe with needle shield after use in a puncture-resistant container.
Throw away (dispose of) EBGLYSS that has been left at room temperature for longer than 7 days.

If anything else happened to the product, or you are unsure, Contact the manufacturer at 1-800-545-5979 (the number printed on the label) about this product.

Where the label prints this number
Store the Pen in a safe place to avoid an accidental needlestick and contact Lilly at 1-800-Lilly-Rx (1-800-545-5979) for instructions on how to return the Pen.
All storage statements on the label (14)
  • Store refrigerated at 2°C to 8°C (36°F to 46°F).
  • If necessary, EBGLYSS can be stored at room temperature up to 30°C (86°F) for up to 7 days in the original carton.
  • Dispose of EBGLYSS that has been left at room temperature for longer than 7 days.
  • Store in the original carton to protect from light until use.
  • Do not freeze.
  • Do not use EBGLYSS if it has been frozen.
  • Do not shake.
  • Discard the EBGLYSS single-dose prefilled pen or prefilled syringe with needle shield after use in a puncture-resistant container.
  • Parts of the EBGLYSS Pen Preparing to inject EBGLYSS Gather supplies and EBGLYSS Pen: EBGLYSS Pen from the refrigerator 1 alcohol wipe 1 cotton ball or piece of gauze 1 sharps disposal container (See Disposing of EBGLYSS ) Note: You do not need to allow your Pen to warm up to room temperature before use.
  • Do not use the Pen (see Disposing of EBGLYSS ) if the: Pen looks damaged medicine is frozen medicine is cloudy, is discolored, or has particles expiration date printed on the label has passed Wash your hands with soap and water Choose and clean your injection site Your healthcare provider can help you choose the injection site that is best for you.
  • Store EBGLYSS in the refrigerator between 36°F to 46°F (2°C to 8°C).
  • EBGLYSS can be stored at room temperature up to 86°F (30°C) for up to 7 days in the original carton.
  • Throw away (dispose of) EBGLYSS that has been left at room temperature for longer than 7 days.
  • Store EBGLYSS in the original carton to protect from light until use.

FDA label version 13, effective June 9, 2026. DailyMed

Dosing and titration calendar

Built only from the schedules the label states (loading, titration, day schedules, cycles and weight bands). Steps the label states in words the calendar cannot place are shown, not guessed.

Loading dosing schedules…

Medicare Part D coverage

45%of plans list it
96%of those: prior authorization
0%step therapy
58%quantity limit
98%specialty tier

5,496 Part D plans, CMS formulary files 2026Q3. Look up tier, PA, step therapy and quantity limits by plan

Patient assistance

No manufacturer program page is listed for this drug yet.

Independent foundations and the full directory (checked 2026-11-06). Eligibility and amounts are set by each program; open its page for them.

For licensed clinicians. Use with clinical judgment. Statements are quoted from the FDA label; confirm against the label for the product you are using.